Anders Hinsby

Anders brings 25 years of experience in biotech leadership and venture capital investment.

Prior to joining Muna, he co-founded and was CEO of Orphazyme, creating an ambitious and mature clinical stage pipeline in rare protein misfolding and lysosomal storage diseases.